Skip to Main Content

Paper Details

Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy.
Nat Commun
14
2022
CD8 T cell, Locally advanced cancers, MMAE, Monomethyl auristatin, Monomethyl auristatin antibody, auristatin, cancer, irradiated tumors, monomethyl auristatin E, normal tissue, patient, tumor, tumor immune infiltrate
Author NameAffiliation
Michael M AllevatoUniversity of California San Diego
Alfredo A MolinoloUniversity of California San Diego
Alfredo A Molinolouniversity of california san diego, Moores Cancer Center
Alfredo A MolinoloUniversity of California San Diego
Alfredo A Molinolouniversity of california san diego, Moores Cancer Center
Ezra E W Cohenuniversity of california san diego, Moores Cancer Center
Ezra E W CohenUniversity of California San Diego
Jorge Silvio GutkindUniversity of California San Diego
Jorge Silvio Gutkinduniversity of california san diego, Moores Cancer Center
Sunil J AdvaniUniversity of California San Diego
Sunil J Advaniuniversity of california san diego, Moores Cancer Center
  • 1 - 11

Datasets

Release 1.2